Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report

INTRODUCTION: In patients with chronic myeloid leukemia, tyrosine kinase inhibitors suppress the BCR-ABL(+ )clone and often induce complete molecular remissions. Megakaryocytes in such patients have been shown to be derived from the BCR-ABL(+ )clone, and abnormal platelet function is frequent in chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimabukuro-Vornhagen, Alexander, Rothe, Achim, Nogova, Lucia, Kochanek, Matthias, Scheid, Christoph, von Bergwelt-Baildon, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117828/
https://www.ncbi.nlm.nih.gov/pubmed/21624109
http://dx.doi.org/10.1186/1752-1947-5-215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117828/
https://www.ncbi.nlm.nih.gov/pubmed/21624109
http://dx.doi.org/10.1186/1752-1947-5-215

Ejemplares similares